Novel Treatments & Drugs

Immunotherapy Might Not Be a Good Option for Mesothelioma

June 20, 2025
Categories: , , , , , ,

Mesothelioma is a rare and aggressive cancer mainly caused by asbestos exposure that creates challenges for patients and caregivers. Immune checkpoint inhibitors have brought hope to patients, but new data from Australia is raising questions about their safety and effectiveness. In order to make informed decisions, patients must understand all details about immunotherapy so they…

CRS and HIPEC for Peritoneal Mesothelioma

May 30, 2025
Categories: , , , , , , ,

Peritoneal mesothelioma is a rare and aggressive cancer linked to asbestos exposure. A promising option for treating the cancer includes cytoreductive surgery (CRS) with heated chemotherapy (HIPEC). A new article explains cytoreductive surgery and HIPEC for the treatment of peritoneal mesothelioma. Cytoreductive surgery removes as many tumors as possible. In the case of peritoneal mesothelioma,…

Immunotherapy to Treat Pleural Mesothelioma

April 25, 2025
Categories: , , , , ,

Malignant pleural mesothelioma is a rare and very aggressive cancer with a poor outlook. One cancer treatment has brought hope though. The treatment is known as immune checkpoint inhibitors. There is potential for better outcomes when patients are given this treatment. A new article in Open Respiratory Archives provides a history of recent advances in…

Drug Factories to Treat Mesothelioma

February 14, 2025
Categories: , , ,

Researchers from Rice University and Baylor College of Medicine developed a new treatment that can eliminate advanced stage mesothelioma tumors in mice within days. The breakthrough treatment used Rice’s cytokine drug factory implants with a checkpoint inhibitor drug. This combination is showing great potential in mesothelioma preclinical trials. The treatment involves tiny drug producing beads,…

Decision Making Tools for Mesothelioma

February 7, 2025
Categories: , , ,

Mesothelioma, a cancer mainly caused by asbestos exposure, is very rare and aggressive. There are many challenges that doctors face when diagnosing, treating, and managing this cancer. Advances in medical technology and data analytics are helping doctors make crucial decisions for patients struggling with the hard to treat and deadly cancer. An article from the…

Immune Checkpoint Inhibitors for the Treatment of Mesothelioma

August 30, 2024
Categories: , , , , ,

Mesothelioma is a rare, aggressive cancer mainly caused by asbestos exposure. One treatment that is giving hope to patients and caregivers is the use of immune checkpoint inhibitors. A new study from Australia has raised questions about the effectiveness and safety of this novel treatment. In order to best care for patients, caregivers need to…

Using Precision Cut Tumor Slices to Advance Mesothelioma Treatment

August 2, 2024
Categories: , , , ,

Malignant pleural mesothelioma is a cancer mainly caused by asbestos exposure that is very deadly. Research continues to be done on the cancer, giving hope to patients and their families. One tool in the fight against mesothelioma is ex-vivo models using precision cut tumor slices. A new article looks at ex-vivo models and precision cut…

Targeting uPARAP Could Improve Mesothelioma Treatment

March 28, 2024
Categories: , , , ,

Mesothelioma is a hard cancer to treat that has low survival rates. This makes it a problem for doctors and researchers. A new study is looking to change this by looking at the collagen receptor uPARAP. The current clinical trial is looking at uPARAP, a protein that is found in higher levels in mesothelioma cells.…

3D Printing and Optical Scanning Can Improve Mesothelioma Treatment

March 22, 2024
Categories: , , ,

New treatments and technologies offer hope for mesothelioma patients. One technology, 3D printing and optical scanning, has the potential to help those suffering with mesothelioma. The technologies refine and enhance what is known as photodynamic therapy, a promising new approach for the management of mesothelioma. Photodynamic therapy is a unique treatment that uses light to…

ADI-PEG20 Improves Survival in Mesothelioma Patients

March 1, 2024
Categories: , , , , ,

ADI-PEG20 is showing promising results for mesothelioma. It is the first treatment to be fully incorporated with chemotherapy in 20 years. The drug will bring hope to thousands of mesothelioma survivors and their families. The drug works by blocking a cancer’s food supply, preventing the spread of the cancer. It does this by absorbing the…